This wiki has undergone a migration to Confluence found Here
Difference between revisions of "20180330 PLA call"
Jump to navigation
Jump to search
(Created page with "{{subst:: PLA Template}}") |
|||
| Line 77: | Line 77: | ||
===Agenda=== | ===Agenda=== | ||
Agenda review | Agenda review | ||
| − | *Notes of [[ | + | *Notes of [[20180316_PLA_call]] review |
| + | *Discussion | ||
| + | **V2 Publishing Mission and Charter (as edited by SGB) | ||
| + | **CIMI-MG candidates | ||
*notional division of products into product families and lines, to provide examples for peer review. | *notional division of products into product families and lines, to provide examples for peer review. | ||
**Level of granularity | **Level of granularity | ||
Revision as of 21:16, 28 March 2018
return to HL7 Product Line Architecture Meeting Minutes and Agendas
Return to HL7 Product Line Architecture Program
| HL7 PLA Call Minutes Location: Phone: +1 770-657-9270, Participant Code: 985371, |
Date: 2017-mm-dd Time: 11:30 AM | ||
| Facilitator | Mary Kay/ Austin | Note taker(s) | Anne |
| Attendee | Name
| ||
| Calvin Beebe | |||
| Lorraine Constable | |||
| Jean Duteau, | |||
| Tony Julian | |||
| Paul Knapp | |||
| Austin Kreisler, | |||
| Mary Kay McDaniel | |||
| Brian Pech | |||
| Wayne Kubick | |||
| John Roberts | |||
| Andy Stechishin | |||
| no quorum definition | |||
Agenda
Agenda review
- Notes of 20180316_PLA_call review
- Discussion
- V2 Publishing Mission and Charter (as edited by SGB)
- CIMI-MG candidates
- notional division of products into product families and lines, to provide examples for peer review.
- Level of granularity
- Identify which pieces are orphaned, and the political elements to be surfaced.
- Positioning cross-product family artifacts (standards naming)
- BAM-lite feedback and review
- Governance on V2.x (v2.9 substantive changes)
- develop form to request establishing a Product Family
Minutes
Convened
Adjourned
Meeting Outcomes
| Actions
|
| Next Meeting/Preliminary Agenda Items |
© 2017 Health Level Seven® International. All rights reserved
